Search

everythinglearnresearchcommunity

for

Search:↓

Topical corticosteroids are the main treatment for Erosive Pustular Dermatosis, but recurrence is common after stopping treatment.

COVID-19 may cause temporary hair loss, which usually gets better on its own, but reducing stress and managing health issues might help recovery.

The congress highlighted concerns about the effectiveness of over-the-counter nail treatments, the link between hair loss and daily care products, and the safety of skin treatments during COVID-19.

RHUPUS should be considered in children with deforming arthritis.

Topical treatment is recommended for Folliculitis decalvans in pregnant women.

Autoimmune Polyendocrine Syndromes involve specific combinations of endocrine and non-endocrine autoimmune diseases.

DCPA is a chronic skin condition affecting the legs, often misdiagnosed, and needs more research for better understanding and treatment.

Hair cortisol levels peak in the third trimester and decline postpartum.

Combination therapies are more effective for treating androgenetic alopecia than single treatments.

SARS-CoV-2 might infect and multiply in skin tissue, possibly aiding in its transmission.

Women with PCOS may have a higher risk of severe COVID-19 due to hormonal imbalances and vitamin D deficiency.

A patient with pemphigus vulgaris improved significantly after treatment for an additional viral skin infection.

The paper concludes that recognizing bitemporal alopecia areata is important for early treatment and preventing its progression.

Alopecia Areata is an autoimmune hair loss condition, with various treatments showing mixed effectiveness and no guaranteed cure.

Topical patidegib gel effectively treats basal cell carcinoma in Gorlin syndrome patients without causing the side effects seen with oral treatments.

Finasteride may help treat hidradenitis suppurativa in children, but concerns exist about ethics, safety, and proper use.

A woman's hair grew back after stopping acitretin for psoriasis and getting steroid treatment, and low vitamin D might be linked to alopecia severity.

The document concludes that alopecia areata is an unpredictable autoimmune hair loss condition with no cure, but various treatments exist that require personalized approaches.

Hair follicles are important for drug delivery through the skin, but better methods are needed to understand and improve this process.

Genetic hair disorders can indicate other hidden health problems.

Chemotherapy can cause skin side effects that affect patients' lives, but they can be managed to avoid interrupting cancer treatment.

The document says a skin condition called alopecia areata causes hair loss and stress, and is treated with strong skin creams, injections, or other therapies, but treatment success varies.

Platelet-rich plasma treatment is not very effective for chronic severe alopecia areata.

Use of cosmeceuticals during pregnancy and breastfeeding is not recommended due to insufficient safety data.

Effective acne treatment and patient education are crucial to prevent long-term physical and psychological effects.

Infliximab can trigger lupus-like symptoms in Crohn's disease patients.

The document concludes that dermatology training and grading scales need to better represent dark-skinned individuals to improve diagnosis and assessment of skin conditions.

Naproxen effectively treated a girl's eosinophilic pustular folliculitis when other treatments failed.

The document concludes that the skin is a complex organ providing protection, sensation, and healing, with challenges in treating conditions like itchiness.

Teen hair loss is common, can be caused by genetics or health issues, and can be diagnosed and treated.